JP2021526808A5 - - Google Patents
Info
- Publication number
- JP2021526808A5 JP2021526808A5 JP2020568252A JP2020568252A JP2021526808A5 JP 2021526808 A5 JP2021526808 A5 JP 2021526808A5 JP 2020568252 A JP2020568252 A JP 2020568252A JP 2020568252 A JP2020568252 A JP 2020568252A JP 2021526808 A5 JP2021526808 A5 JP 2021526808A5
- Authority
- JP
- Japan
- Prior art keywords
- edb
- xaa
- cys
- binding peptide
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EPPCT/EP2018/065205 | 2018-06-08 | ||
| PCT/EP2018/065205 WO2019233605A1 (en) | 2018-06-08 | 2018-06-08 | Compositions and methods for diagnosis and treatment of cancer |
| PCT/EP2019/064872 WO2019234190A1 (en) | 2018-06-08 | 2019-06-06 | Compositions and methods for diagnosis and treatment of cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021526808A JP2021526808A (ja) | 2021-10-11 |
| JP2021526808A5 true JP2021526808A5 (https=) | 2023-04-17 |
| JP7466466B2 JP7466466B2 (ja) | 2024-04-12 |
Family
ID=62636178
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020568252A Active JP7466466B2 (ja) | 2018-06-08 | 2019-06-06 | 癌の診断および治療のための組成物および方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11673939B2 (https=) |
| EP (1) | EP3802585A1 (https=) |
| JP (1) | JP7466466B2 (https=) |
| KR (2) | KR20240142617A (https=) |
| CN (2) | CN112424220A (https=) |
| AU (1) | AU2019282316B2 (https=) |
| BR (1) | BR112020024034A2 (https=) |
| CA (1) | CA3101246A1 (https=) |
| MX (1) | MX2020013205A (https=) |
| WO (2) | WO2019233605A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019233605A1 (en) * | 2018-06-08 | 2019-12-12 | BioNTech SE | Compositions and methods for diagnosis and treatment of cancer |
| KR102649794B1 (ko) * | 2020-10-19 | 2024-03-22 | 고려대학교 산학협력단 | 암 및/또는 뇌질환 바이오마커인 엑스트라-도메인 b 파이브로넥틴 및 이를 이용한 진단 방법 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020111302A1 (en) | 2000-11-30 | 2002-08-15 | Y. Tom Tang | Novel nucleic acids and polypeptides |
| WO2007004060A2 (en) * | 2005-05-05 | 2007-01-11 | Valorisation Hsj, Societe En Commandite | Cytokine receptor modulators and uses thereof |
| EP1892248A1 (en) * | 2006-08-21 | 2008-02-27 | Eidgenössische Technische Hochschule Zürich | Specific and high affinity binding proteins comprising modified SH3 domains of FYN kinase |
| CA2741040C (en) * | 2008-10-20 | 2015-09-22 | Gwangju Institute Of Science And Technology | Bipodal-peptide binder |
| CA2822938A1 (en) * | 2010-12-27 | 2012-07-05 | Apo-T B.V. | A polypeptide that binds aberrant cells and induces apoptosis |
| AU2014252354A1 (en) * | 2013-04-11 | 2015-11-19 | Merck Patent Gmbh | Potent inhibitors of human matriptase derived from McotI-II variants |
| WO2016022597A1 (en) * | 2014-08-04 | 2016-02-11 | Case Western Reserve University | Targeting peptides and methods of use |
| WO2016146174A1 (en) | 2015-03-17 | 2016-09-22 | Biontech Ag | Compositions and methods for diagnosis and treatment of cancer |
| TWI799366B (zh) | 2015-09-15 | 2023-04-21 | 美商建南德克公司 | 胱胺酸結骨架平臺 |
| US20170218040A1 (en) * | 2016-02-02 | 2017-08-03 | Julio A. Camarero Palao | Proteolically resistant cyclotides with angiotensin 1-7 like activity |
| WO2019233605A1 (en) * | 2018-06-08 | 2019-12-12 | BioNTech SE | Compositions and methods for diagnosis and treatment of cancer |
-
2018
- 2018-06-08 WO PCT/EP2018/065205 patent/WO2019233605A1/en not_active Ceased
-
2019
- 2019-06-06 BR BR112020024034-6A patent/BR112020024034A2/pt not_active Application Discontinuation
- 2019-06-06 EP EP19728093.6A patent/EP3802585A1/en active Pending
- 2019-06-06 WO PCT/EP2019/064872 patent/WO2019234190A1/en not_active Ceased
- 2019-06-06 KR KR1020247031593A patent/KR20240142617A/ko active Pending
- 2019-06-06 CA CA3101246A patent/CA3101246A1/en active Pending
- 2019-06-06 US US16/972,794 patent/US11673939B2/en active Active
- 2019-06-06 AU AU2019282316A patent/AU2019282316B2/en not_active Ceased
- 2019-06-06 CN CN201980045963.4A patent/CN112424220A/zh active Pending
- 2019-06-06 KR KR1020207035142A patent/KR20210020006A/ko not_active Ceased
- 2019-06-06 MX MX2020013205A patent/MX2020013205A/es unknown
- 2019-06-06 JP JP2020568252A patent/JP7466466B2/ja active Active
- 2019-06-06 CN CN202310907634.4A patent/CN116987180A/zh active Pending
-
2023
- 2023-04-20 US US18/303,642 patent/US12516104B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sutoh | Identification of myosin-binding sites on the actin sequence | |
| Bockaert et al. | The ‘magic tail’of G protein-coupled receptors: an anchorage for functional protein networks | |
| Serrano et al. | Controlled proteolysis of tubulin by subtilisin: localization of the site for MAP2 interaction | |
| JP4336771B2 (ja) | 血清アルブミン結合部分 | |
| US20020147306A1 (en) | Peptides that modulate the interaction of B class ephrins and PDZ domains | |
| Kachi et al. | Detailed localization of photoreceptor guanylate cyclase activating protein-1 and-2 in mammalian retinas using light and electron microscopy | |
| Wang et al. | Existence and functions of a kisspeptin neuropeptide signaling system in a non-chordate deuterostome species | |
| Wilson et al. | Distribution of alpha-bungarotoxin binding sites over residues 173-204 of the alpha subunit of the acetylcholine receptor. | |
| Saini et al. | Structural determinants of ubiquitin-CXC chemokine receptor 4 interaction | |
| JP2021526808A5 (https=) | ||
| JP2024015143A5 (https=) | ||
| Gupta et al. | Probing interactions between CLIP-170, EB1, and microtubules | |
| Asano et al. | Localization of various forms of the γ subunit of G protein in neural and nonneural tissues | |
| Kuwabara et al. | Mapping of the minimal domain encoding a conformational epitope by λ phage surface display: factor VIII inhibitor antibodies from haemophilia A patients | |
| EP1683866B1 (en) | Deletion forms of IgE-dependent histamine releasing factor having histamine-releasing activity, HRF-binding peptides and the uses thereof | |
| JPH111493A (ja) | ペプチドおよびこれを固定化してなる医療材料 | |
| JP4127861B2 (ja) | シナプス活性化タンパク質組成物および方法 | |
| CN116120405A (zh) | 一种抑制TSLP与TSLP/IL-7Rα受体结合的多肽及其用途 | |
| Hansen et al. | Identification of a homologous heparin binding peptide sequence present in fibronectin and the 70 kDa family of heat-shock proteins | |
| Tripet et al. | Kinetic analysis of the interactions between Troponin C (TnC) and Troponin I (TnI) binding peptides: evidence for separate binding sites for the ‘structural’N‐terminus and the ‘regulatory’C‐terminus of TnI on TnC | |
| KR20230057076A (ko) | 카스파제-3 검출용 신규한 펩타이드 | |
| NZ770391A (en) | Compositions and methods for diagnosis and treatment of cancer | |
| NZ770391B2 (en) | Compositions and methods for diagnosis and treatment of cancer | |
| EP3611183B1 (en) | Epitope peptide specifically recognizing autoantibody against aquaporin 5, and use thereof | |
| WO2018130170A1 (zh) | 一种肿瘤坏死因子alpha的高亲和性肽及其应用 |